Literature DB >> 1094880

Pneumocystis carinii pneumonia: a cluster of eleven cases.

C Singer, D Armstrong, P P Rosen, D Schottenfeld.   

Abstract

An unusual cluster of 11 patients with Pneumocystis carinii pneumonia occurred in a 3-month period at Memorial Hospital, New York. Ten of the 11 patients had lymphoma or leukemia. In 7 patients, corticosteroid therapy was decreased or stopped shortly before pneumocystis pneumonia was diagnosed. The pediatric patients had extensive contact in the outpatient department, and three of them had roomed together, suggesting the possibility of man to man transmission. Tree of 4 adult patients with Hodgkin's disease and pneumocystis pneumonia had the same physician. This physician had an indirect immunofluorescent titer of 1:16, as did an infectious disease resident involved in the care of 6 patients. Three of 9 patients tested showed indirect immunofluorescent titers of 1:16 or above, with rising or falling titers on serial specimens. Although definitive evidence of communicability was not established, patients with suspected or proved pneumocystis pneumonia are now isolated in this hospital.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094880     DOI: 10.7326/0003-4819-82-6-722

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

Review 1.  Extrapulmonary pneumocystosis.

Authors:  V L Ng; D M Yajko; W K Hadley
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Clinical manifestations of infections with herpesviruses after kidney transplantation: a prospective study of various syndromes.

Authors:  S Naraqi; O Jonasson; G G Jackson; H M Yamashiroya
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

Review 3.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

4.  Pneumocystis carinii pneumonia in HIV-negative patients with haematologic disease.

Authors:  J van der Lelie; D Venema; E J Kuijper; R P van Steenwijk; M H van Oers; L L Thomas; A E von dem Borne
Journal:  Infection       Date:  1997 Mar-Apr       Impact factor: 3.553

5.  Pneumocystis carinii, Toxoplasma gondii, Cytomegalovirus and the compromised host.

Authors:  F W Ryning; J Mills
Journal:  West J Med       Date:  1979-01

6.  Pneumocystis carinii pneumonia in heart transplant recipients.

Authors:  P Grossi; G B Ippoliti; C Goggi; P Cremaschi; M Scaglia; L Minoli
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

7.  Outbreak of Pneumocystis carinii pneumonia in a renal transplant unit.

Authors:  C Hennequin; B Page; P Roux; C Legendre; H Kreis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

8.  Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.

Authors:  M A Powles; D C McFadden; L A Pittarelli; D M Schmatz
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

10.  Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study.

Authors:  Elodie Senggen Manoloff; Patrick Francioli; Patrick Taffé; Guy Van Melle; Jacques Bille; Philippe M Hauser
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.